Statistics for Cytek Biosciences, (id:7709 CTKB)

Valuation metrics

Market cap

906.83M

Enterprise value

643.57M

Trailing P/E (ttm)

374.50

Forward P/E

117.33

PEG ratio

117.33

Price/Sales (ttm)

4.51

Price/Book (mrq)

2.37

Enterprise Value/Revenue

3.20

Enterprise Value/EBITDA

-42.46

Overview

Shares outstanding

128.81M

Float

110.66M

Shares short

4.20M

% Held by insiders

0.09%

% Held by institutions

0.59%

Average volume (10 days)

1.24M

Average volume (90 days)

Price summary

52-Week low

4.66

52-Week high

9.87

52-Week change

-14.03%

Beta

1.32

50-Day moving average

5.32

200-Day moving average

6.17

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

-5.05%

Operating margin

-8.25%

Operational effectiveness

Return on assets

-2.74%

Return on equity

-2.54%

Income statement

Revenue (ttm)

1.53

Revenue per share (ttm)

1.53

Quarterly revenue growth (yoy)

Gross profit (ttm)

109.43M

EBITDA

-15,157,000.00

Net income to common (ttm)

-10,160,000.00

Diluted EPS (ttm)

-0.08

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

277.78M

Total cash per share (mrq)

2.16

Total debt (mrq)

14.52M

Total Debt/Equity (mrq)

3.77

Current ratio (mrq)

621.40%

Book value per share (mrq)

2.97

Cash flow

Cash flow statement

32.89M

Levered free cash flow (LFCF)

40.66M